Evaluation of natural killer cell defense in oral squamous cell carcinoma

Oral Oncology

Volumn 46, Issue 5, 2010, Pages

  Türkseven, Mahiye Reyhan ^a   Oygür, Tülin ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Cytokines; Natural killer cell; Oral cancer; Tumor immunity

Indexed keywords

CD57 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD57; CARCINOMA, SQUAMOUS CELL; CELL COUNT; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77950858366     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.02.019     Document Type: Article

References (24)

1. The World Health Report 1998. Life in the 21st century. A vision for all. Report of the Director General. World Health Organization 1998;103:88-90.
2. Odel E.W., and Morgan P.R. Biopsy pathology of the oral tissues. 1st ed. (1998), Chapman and Hall, London
3. Cotran R.S., Kumar V., and Collins T. Robbin's pathologic basis of disease. 6th ed. (1999), WB Saunders Co., Philadelphia
4. Whiteside T.L., Letessier E., Hirabayashi H., Vitolo D., Bryant J., Barnes L., et al. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of head and neck. Cancer Res 53 (1993) 5654-5662
5. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Che X., Iwashige H., et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88 (2000) 553-577
6. Miller J.S. Biology of natural killer cells in cancer and infection. Cancer Invest 20 3 (2002) 405-419
7. Partridge M., Li S.R., Pateromichelakis S., Francis R., Phillips E., Huang X.H., et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 6 7 (2000) 2718-2725
8. Beahrs O.H., Henson D.E., Hutter R.V.P., and Kennedy B.J. Manual for staging of cancer. American joint committee on cancer. 4th ed. (1992), Lippincott, Philadelphia
9. Bryne M., Koppang H.S., Lilleng R., Stene T., Bang G., and Dabelsteen E. New malignancy grading is a prognostic indicator than Broder's grading in oral squamous cell carcinoma. J Oral Pathol Med 18 (1989) 432-437
10. Whiteside T.L., Chikamatsu K., Nagashima S., and Okada K. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer. Anticancer Res 16 (1996) 2357-2364
11. Foss F.M. Immunologic mechanism of antitumor activity. Semin Oncol 29 Suppl. 7 (2002) 5-11
12. Garrido F., and Algarra I. MHC antigens and tumor escape from immune surveillance. Adv Cancer Res 83 (2001) 117-158
13. Cabrera T., Salinero J., Fernandez M.A., Garrido A., Esquivias J., and Garrido F. High frequency of altered HLA class I phenotypes in laryngeal carcinomas. Hum Immunol 61 5 (2000) 499-506
14. Esteban F., Concha A., Delgado M., Perez-Ayala M., Ruiz-Cabello F., and Garrido F. Lack of MHC class I antigens and tumor aggressiveness of the squamous cell carcinoma of the larynx. Brit J Cancer 62 (1990) 1047-1051
15. Cruz I., Meijer C.J.L.M., Walboomers J.M.M., Snijders P.J.F., and Van Der Waal I. Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas. Brit J Cancer 81 5 (1999) 881-889
16. Schantz S.P., and Ordonez N.G. Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat Immun Cell Growth Regul 10 5 (1991) 278-288
17. Kurosawa S., Harada M., Matsi{dotless}zaki G., Shinomiya Y., Terao H., and Kobayashi N. Early-appearing tumor-infiltrating natural killer cells play a crucial role in the generation of antitumor T lymphocytes. Immunology 85 (1995) 338-346
18. Harabuchi Y., Yamanaka N., and Kataura A. Identification of lymphocytes subsets and natural killer cells in head and neck cancers. Arch Otorhinolaryngol 242 (1985) 89-97
19. Ugolini S., and Vivier E. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Curr Opin Immunol 12 3 (2000) 295-300
20. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95 8 (1998) 4510-4515
21. Aractingi S., Kanitakis J., Eurrard S., Le Danff C., and Carosella E.D. Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients. Int J Cancer 106 2 (2003) 232-235
22. Mann E.A., Hibbs M.S., Spiro J.D., Bowik C., Wang X.S., Clawson M., et al. Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: the role of the tumor necrosis factor-alpha. Ann Otol Rhino Laryngol 104 3 (1995) 203-209
23. Jewett A., Cavalcanti M., and Bonavida B. Pivotal role of endogenous TNFα in the induction of functional inactivation and apoptosis in NK cells. J Immunol 159 (1997) 4815-4822
24. Suvendu Das C., and Varalakshmi A.K. Target-cell-induced anergy in natural killer cells: suppression of cytotoxic function. Cancer Immunol Immunother 49 (2000) 109-115